Mood Therapeutics: Novel Pharmacological Approaches for Treating Depression
about
Adaptor Protein APPL2 Affects Adult Antidepressant Behaviors and Hippocampal Neurogenesis via Regulating the Sensitivity of Glucocorticoid Receptor.Novel treatment options in depression and psychosis.Therapeutic endocannabinoid augmentation for mood and anxiety disorders: comparative profiling of FAAH, MAGL and dual inhibitors.Leptin in depression: a potential therapeutic target
P2860
Mood Therapeutics: Novel Pharmacological Approaches for Treating Depression
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Mood Therapeutics: Novel Pharmacological Approaches for Treating Depression
@en
type
label
Mood Therapeutics: Novel Pharmacological Approaches for Treating Depression
@en
prefLabel
Mood Therapeutics: Novel Pharmacological Approaches for Treating Depression
@en
P2093
P2860
P50
P1476
Mood Therapeutics: Novel Pharmacological Approaches for Treating Depression
@en
P2093
Carlos A Zarate
Philip W Gold
Rafael T de Sousa
P2860
P304
P356
10.1080/17512433.2017.1253472
P407
P577
2016-10-26T00:00:00Z